Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00472_DB00865_nanopub.RAKzkJIeBhKIKsbrB6n-8T25LqOTS7TJqio0Fz1W0Agb8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00472_DB00865 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00472_DB00865 label "DDI between Fluoxetine and Benzphetamine - Amphetamines may enhance the adverse/toxic effect of Serotonin Modulators. The risk of serotonin syndrome may be increased. Monitor patients closely for signs and symptoms of serotonin syndrome (e.g., agitation, tremor, tachycardia, etc.) when using amphetamines and serotonin modulators in combination. [drugbank_resource:DB00472_DB00865]" assertion.
- drugbank_resource:DB00472_DB00865 identifier "drugbank_resource:DB00472_DB00865" assertion.
- drugbank_resource:DB00472_DB00865 title "DDI between Fluoxetine and Benzphetamine - Amphetamines may enhance the adverse/toxic effect of Serotonin Modulators. The risk of serotonin syndrome may be increased. Monitor patients closely for signs and symptoms of serotonin syndrome (e.g., agitation, tremor, tachycardia, etc.) when using amphetamines and serotonin modulators in combination." assertion.
- drugbank:DB00472 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00472_DB00865 assertion.
- drugbank:DB00865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00472_DB00865 assertion.